PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Chemo may be preferred option for some with advanced prostate cancer

Small study suggests that presence of gene variant can be used to select best treatment

2015-06-09
(Press-News.org) In a small clinical trial, scientists at Johns Hopkins' Kimmel Cancer Center and James Buchanan Brady Urological Institute found that men with advanced prostate cancer and detection of androgen receptor splice variant-7 (AR-V7) respond to chemotherapy just as well as men who lack the variant.

The findings, the researchers say, may be significant for patients who carry the AR-V7 variant, because they are more likely to develop resistance to one of two hormone drugs routinely used to treat their disease. Results of the trial are published online in the June 4 issue of JAMA Oncology.

"Our study shows that men who have the AR-V7 gene variant and usually don't respond to either abiraterone or enzalutamide, are not at a disadvantage when given chemotherapy drugs," says Emmanuel Antonarakis, M.D., an oncologist at the Kimmel Cancer Center. Seven of the 17 men in the trial who carried the AR-V7 variant and received chemotherapy experienced a 50 percent reduction in their prostate-specific antigen (PSA) level.

The National Cancer Institute estimates that more than 220,000 men will be diagnosed with prostate cancer in 2015 and more than 27,000 will die from it. Approximately 5 percent (11,000) of patients with prostate cancer have advanced disease.

The AR-V7 gene variant was discovered in 2008 by James Buchanan Brady Urological Institute researcher Jun Luo, Ph.D. In a previous study, Luo and Antonarakis found that men with the AR-V7 variant were resistant to hormonal drugs, such as enzalutamide or abiraterone, which are androgen receptor-directed therapies used for treating the type of advanced cancer called castration-resistant prostate cancer.

Abiraterone and enzalutamide, says Antonarakis, aim to block the production and function of male hormones. The AR-V7 variant codes for shortened proteins that, unlike full-length AR proteins, regulate prostate cancer growth, which is not dependent on male hormones, or androgens. Therefore, men who have the AR-V7 variant are more likely to be resistant to hormone drugs, rendering them ineffective.

In the new trial with 37 men being treated with either of two chemotherapy drugs, docetaxel or cabazitaxel, at The Johns Hopkins Hospital, 17 had detectable levels of the AR-V7 variant in their blood. In comparing men with and without the gene variant, there was no statistical difference in how much patients' PSA levels declined, how long it took for their cancers to progress or their overall survival. PSA levels are markers for prostate cancer.

In a previous clinical trial of 62 patients with castraction-resistant prostate cancer, the same researchers found that 18 AR-V7-positive patients who took either enzalutamide or abiraterone showed no reduction in their PSA levels, indicating that the drugs were not effective in these patients. However, the current study showed that seven of 17 (41 percent) AR-V7-positive patients receiving chemotherapy achieved a 50 percent reduction in PSA levels.

Taken together, Antonarakis says, the findings, if confirmed in larger trials, suggest that the presence of the AR-V7 variant could be used someday as a biomarker to improve treatment decision-making for patients with prostate cancer.

When some patients take either enzalutamide or abiraterone, the drug stops working, and their cancer grows and spreads, explains Antonarakis. The incidence of AR-V7 among these patients may be as high as 30 to 40 percent, he notes.

"It would be very useful to know if such patients are AR-V7-positive," Antonarakis says, "because if they were, a better step for them might be chemotherapy rather than the alternative androgen receptor-directed hormonal therapy."

"We think AR-V7 would have the greatest utility as a biomarker to guide further treatment in men with castration-resistant prostate cancer, and not for earlier stages of the disease so far," Luo says. "But that's something we should test in further studies."

The researchers also detected what they say is an intriguing change among seven of the patients in the study who were AR-V7-positive at the start of their chemotherapy: During the course of that treatment, they converted to AR-V7-negative. "The clinical significance of this is unknown, but one hypothesis is that some of these patients could possibly become re-sensitized to enzalutamide or abiraterone."

There is no commercially available test yet for AR-V7, Antonarakis notes, which is detected in tumor cells circulating in a patient's blood. But Luo and Antonarakis say that they are working to develop and validate an AR-V7 test that could be used more widely.

"The ultimate goal is to address needs of patients who are failing standard therapy," says Luo. "By using the biomarker to improve patient-doctor decision-making, we could realize a therapeutic benefit without having to find a new drug."

The researchers also note that the two hormone therapies, abiraterone and enzalutamide, are considerably more expensive than chemotherapy. At more than $30,000 for a six-month treatment, the hormone-based therapies are more than double the chemotherapy costs.

INFORMATION:

Other Johns Hopkins scientists who contributed to the study include Changxue Lu, Brandon Luber, Hao Wang, Yan Chen, Mary Nakazawa, Rosa Nadal, Channing J. Paller, Samuel R. Denmeade, Michael A. Carducci and Mario A. Eisenberger.

Antonarakis has served as a paid consultant/advisor for Janssen, Astellas, Sanofi, Dendreon, Essa and Medivation and received research funding from Janssen, Johnson & Johnson, Sanofi, Dendreon, Exelixis, Genentech, Novartis, and Tokai. He is a co-inventor of a technology that has been licensed to Tokai. Luo has served as a paid consultant/advisor for Astellas, been a speaker for Sanofi and Gilead, and received research funding from Sanofi and Mirati. These arrangements are being managed by The Johns Hopkins University in accordance with its conflict-of-interest policies.

Funding for the study was provided by the Prostate Cancer Foundation, the Department of Defense Prostate Cancer Research Program (W81XWH-12-1-0605), the Patrick C. Walsh Fund, the Johns Hopkins Prostate SPORE grant (P50 CA058236) and the National Institutes of Health (P30 CA006973).

On the Web:

JAMA Oncology

Blood Test for 'Nicked' Receptor Predicts Prostate Cancer Treatment Response

Johns Hopkins Kimmel Cancer Center
Office of Public Affairs
Media Contacts:
Vanessa Wasta, 410-614-2916, wasta@jhmi.edu
Amy Mone, 410-614-2915, amone@jhmi.edu



ELSE PRESS RELEASES FROM THIS DATE:

Social media helps young adults quit smoking

2015-06-09
Young adults who use social media to quit smoking are twice as successful in their efforts as those who use a more traditional method, according to new research from the University of Waterloo. The study, published last week in Nicotine & Tobacco Research, compared the success of the social media-based campaign Break It Off with Smokers' Helpline, a telephone hotline for young adults looking to quit smoking. After three months in the program, 32 per cent of smokers who used Break It Off apps and web tools had quit smoking, compared to 14 per cent of their peers who ...

NASA sees the start of India's monsoon season

NASA sees the start of Indias monsoon season
2015-06-09
Monsoon rainfall, although a little later than normal, started on June 5, 2015, in southern India. The Global Precipitation Measurement (GPM) core satellite gathered rainfall data that was used to create an animation that shows where the precipitation fell as the season started. Due to El Nino conditions some meteorologists predict that monsoon rainfall will be below normal this year. Cooling rainfall comes to the country after high temperatures preceding the monsoon have caused the reported deaths of more than 2,300 people. Data from the NASA's Integrated Multi-satellitE ...

NASA sees Blanca blanking out over Baja

NASA sees Blanca blanking out over Baja
2015-06-09
The remnants of former Hurricane Blanca are blanking out over the northern part of Mexico's Baja California today, June 9. NOAA's GOES-West satellite captured an infrared image of Blanca's remnants revealing a disorganized storm. All watches and warnings have been dropped. NOAA's GOES-West satellite took an image of Blanca's remnants as it continued moving over the northern Baja California peninsula on June 9 at 1245 UTC (8:45 a.m. EDT). The clouds associated with the remnants were over the northern Baja and over the northern portion of mainland Mexico. The western-most ...

How atmospheric rivers form

How atmospheric rivers form
2015-06-09
WASHINGTON, DC, June 9, 2015 - If you want to assign blame on an overcast day, then cast your eyes on the tropics. Water vapor originating from the Earth's tropics is transported to midlatitudes on long filaments of flowing air that intermittently travel across the world's oceans. When these airy tendrils make landfall, they can cause severe floods and other extreme weather events. Yet despite the importance of these "atmospheric rivers" for the global water and heat cycles, the mechanism behind their formation is still a mystery. But a new study, published this week ...

Overall rate of traumatic spinal cord injury remains stable in US

2015-06-09
Between 1993 and 2012, the incidence rate of acute traumatic spinal cord injury remained relatively stable in the U.S., although there was an increase among older adults, mostly associated with an increase in falls, according to a study in the June 9 issue of JAMA, a theme issue on the Americans with Disabilities Act. Traumatic spinal cord injury leads to chronic impairment and disability. Despite the substantial effects of this injury on health-related quality of life and health care spending, contemporary data on trends in incidence, causes, and medical care are limited, ...

Control system shows potential for improving function of powered prosthetic leg

2015-06-09
A control system that incorporated electrical signals generated during muscle contractions and gait information resulted in improved real-time control of a powered prosthetic leg for different modes of walking (such as on level ground or descending stairs), according to a study in the June 9 issue of JAMA, a theme issue on the Americans with Disabilities Act. Most prosthetic lower limbs are mechanically passive (cannot provide power) and so do not restore full function. Leg prostheses that provide power are becoming available; however, different ambulation modes require ...

MCAT predicts differently for students who test with extra time

2015-06-09
Among applicants to U.S. medical schools, those with disabilities who obtained extra test administration time for the Medical College Admission Test in use from 1991 to January 2015 had no significant difference in rate of medical school admission but had lower rates of passing the United States Medical Licensing Examination Step examinations and of medical school graduation, according to a study in the June 9 issue of JAMA, a theme issue on the Americans with Disabilities Act. Individuals with documented mental and physical disabilities may receive testing accommodations ...

Examination of gastroenteritis hospitalization rates following use of rotavirus vaccine

2015-06-09
Following implementation of rotavirus vaccination in 2006, all-cause acute gastroenteritis hospitalization rates among U.S. children younger than 5 years of age declined by 31 percent - 55 percent in each of the post-vaccine years from 2008 through 2012, according to a study in the June 9 issue of JAMA. Eyal Leshem, M.D., of the U.S. Centers for Disease Control and Prevention, Atlanta, and colleagues examined both all-cause gastroenteritis and rotavirus-related hospitalizations among children younger than 5 years from 2000 through 2012. The researchers analyzed State ...

INFORMS journal: Microsoft algorithm improves directions in large networks for Bing Maps

2015-06-09
Did the cross-country drive that you planned using an online mapping service take twice as long as expected? In a new study published in the Articles in Advance section of Transportation Science, a journal of the Institute for Operations Research and the Management Sciences (INFORMS), Microsoft researchers working on a project for Bing Maps explain how they developed the first routing engine that satisfies a large number of algorithmic requirements that overcome barriers to generating directions on multi-stage trips like coast-to-coast drives. Customizable Route Planning ...

Are the data underlying the US dietary guidelines flawed?

2015-06-09
Rochester, MN, June 9, 2015 - U.S. government-issued dietary recommendations continue to evolve over time. In a special article published in Mayo Clinic Proceedings, an obesity theorist and cardiovascular health researchers claim that the main source of dietary information used by the U.S. Government's 2015 Dietary Guidelines Advisory Committee (DGAC) is scientifically flawed because the underlying data are primarily informed by memory-based dietary assessment methods (M-BMs) (eg, interviews and surveys). In an editorial response nutrition experts suggest that the purported ...

LAST 30 PRESS RELEASES:

Brain stimulation can boost math learning in people with weaker neural connections

Inhibiting enzyme could halt cell death in Parkinson’s disease, study finds

Neurotechnology reverses biological disadvantage in maths learning

UNDER EMBARGO: Neurotechnology reverses biological disadvantage in maths learning

Scientists target ‘molecular machine’ in the war against antimicrobial resistance

Extending classical CNOP method for deep-learning atmospheric and oceanic forecasting

Aston University research: Parents should encourage structure and independence around food to support children’s healthy eating

Thunderstorms are a major driver of tree death in tropical forests

Danforth Plant Science Center adds two new faculty members

Robotic eyes mimic human vision for superfast response to extreme lighting

Racial inequities and access to COVID-19 treatment

Residential segregation and lung cancer risk in African American adults

Scientists wipe out aggressive brain cancer tumors by targeting cellular ‘motors’

Capturability distinction analysis of continuous and pulsed guidance laws

CHEST expands Bridging Specialties Initiative to include NTM disease and bronchiectasis on World Bronchiectasis Day

Exposure to air pollution may cause heart damage

SwRI, UTSA selected by NASA to test electrolyzer technology aboard parabolic flight

Prebiotics might be a factor in preventing or treating issues caused by low brain GABA

Youngest in class at higher risk of mental health problems

American Heart Association announces new volunteer leaders for 2025-26

Gut microbiota analysis can help catch gestational diabetes

FAU’s Paulina DeVito awarded prestigious NSF Graduate Research Fellowship

Champions for change – Paid time off initiative just made clinical trials participation easier

Fentanyl detection through packaging

Prof. Eran Meshorer elected to EMBO for pioneering work in epigenetics

New 3D glacier visualizations provide insights into a hotter Earth

Creativity across disciplines

Consequences of low Antarctic sea ice

Hear here: How loudness and acoustic cues help us judge where a speaker is facing

A unique method of rare-earth recycling can strengthen the raw material independence of Europe and America

[Press-News.org] Chemo may be preferred option for some with advanced prostate cancer
Small study suggests that presence of gene variant can be used to select best treatment